Omlonti (Omidenepag Isopropyl) for the Reduction of Elevated Intraocular PressureBy KayeOctober 6, 20220 On 22 Sep 2022, the US FDA approved Omlonti® 0.002% eye drops for the reduction of elevated intraocular pressure. Read more
Over $1 Billion to be Spent for Singapore’s Preventive HealthcareBy Rachel TanOctober 4, 20220 Singapore allocates a budget of over $1 billion for the Healthier SG Programme aiming to provide residents with a physician and a health plan.
Thalidomide (Old Drug for New Indication: Multiple Myeloma)By KayeAugust 11, 20220 Thalidomide possesses immunomodulatory, anti-inflammatory and antiangiogenic effects. Find out why it is effective against Myeloma cells
The Art of Packing: Preventive Medications for Your HolidaysBy CherineAugust 10, 20220 Are you planning for your next holiday? Here are tips on medications that will come in handy for your trip
Tepotinib (Tepmetko) for METex14-altered NSCLCBy KayeJuly 27, 20220 Tepotinib (Tepmetko) was recently approved for the use of Non-Small Cell Lung Cancer (NSCLC). Find out about the Phase II VISION trial here.
Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)By KayeJuly 14, 20220 Tumours harness several strategies to avoid elimination by the immune system and exploiting the programmed cell death protein (PD1) is…
Available Birth Control Methods & How To Choose The Right OneBy CherineJuly 12, 20220 Birth control, or contraception, is a method or device used to prevent pregnancy. With so many options out there, learn more about them here.
The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic DermatitisBy KayeJune 30, 20220 Among the many new drug approved for the use of atopic dermatitis or eczema, dupilumab (Dupixent) is one of them. Find out about its evidence here.
Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)By KayeJune 16, 20220 Tumour cells harness multiple resistance mechanisms to evade the host-tumour immune system. Notably, the programmed death 1 (PD1) receptor and…
Biologics For Severe Asthma: A Review of Dupilumab (Dupixent)By KayeJune 2, 20220 Asthma is one of the most common chronic respiratory conditions treated in the primary care setting in Singapore. Critically, it…
